Abstract
8-Hydroxy-2'-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, has been extensively studied to assess human exposure to carcinogenic compounds. Previous studies have associated levels of human urinary hydroxylated polycyclic aromatic hydrocarbons (OH-PAHs) with those of 8-OHdG. However, measurements of OH-PAHs and 8-OHdG in urine are often conducted with two different analytical methods, which is both costly and time-consuming. In this study, a novel method is described to quickly and simultaneously quantify ten urinary OH-PAHs and 8-OHdG through high pressure liquid chromatography/tandem mass spectrometry (HPLC/MS/MS). Urine samples undergo solid phase extraction and concentration and then are analyzed by an optimized HPLC/MS/MS method operated in the negative electrospray ionization (ESI) and multiple reaction monitoring (MRM) mode. Deuterated, (15)N and (13)C- labeled analogues are used as internal standards. Simultaneous analysis of urinary 8-OHdG and OH-PAHs are completed within 16 min. Calibration curves of all target analytes show favorable linearity within the concentration range of 0.3-10.0 μg/L for 8-OHdG and 0.05-15 μg/L for different OH-PAHs. The method detection limits (MDLs) in pooled urine range from 0.023 μg/L to 0.625 μg/L. The method shows satisfactory accuracy and precision when we analyzed varied levels spiked in pooled urine. Recoveries for 8 of the 10 OH-PAHs were in the range of 100 ± 15% with a variation coefficient of less than 20%. Thirty-four real urine samples were analyzed for all target analytes. Except 3-OHF, most compounds could be quantified.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
